SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

24 May 2024 Evaluate
Net sales declined -13.11%  to  Rs. 1338.99 million from Rs. 1541.10 millions.The Net Loss for the quarter ended March 2024 is Rs. -320.01 millions as compared to Net Profit of Rs. 111.53 millions of corresponding quarter ended March 2023The company reported a degrowth in operating Profit to 224.87 millions from 227.44 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1338.99 1541.10 -13.11 4734.18 6457.96 -26.69 4734.18 6457.96 -26.69
Other Income 64.53 7.20 796.25 86.86 15.90 446.29 86.86 15.90 446.29
PBIDT 224.87 227.44 -1.13 849.51 1129.52 -24.79 849.51 1129.52 -24.79
Interest 60.11 59.68 0.72 296.80 175.61 69.01 296.80 175.61 69.01
PBDT -278.52 167.76 -266.02 109.43 953.91 -88.53 109.43 953.91 -88.53
Depreciation 72.98 46.94 55.48 276.20 172.08 60.51 276.20 172.08 60.51
PBT -351.50 120.82 -390.93 -166.77 781.83 -121.33 -166.77 781.83 -121.33
TAX -31.49 9.29 -438.97 -23.49 146.50 -116.03 -23.49 146.50 -116.03
Deferred Tax -31.49 -13.58 131.89 -37.05 -17.08 116.92 -37.05 -17.08 116.92
PAT -320.01 111.53 -386.93 -143.28 635.33 -122.55 -143.28 635.33 -122.55
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 16.79 14.76 13.79 17.94 17.49 2.60 17.94 17.49 2.60

Bajaj Healthcare Share Price

348.95 -1.50 (-0.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×